scispace - formally typeset
M

Masashi Fujita

Researcher at Osaka University

Publications -  86
Citations -  3874

Masashi Fujita is an academic researcher from Osaka University. The author has contributed to research in topics: Stent & Heart failure. The author has an hindex of 27, co-authored 86 publications receiving 3497 citations.

Papers
More filters
Journal ArticleDOI

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.

TL;DR: Short-term statin therapy improves cardiac function, neurohormonal imbalance, and symptoms associated with idiopathic dilated cardiomyopathy and suggest that statins may have therapeutic benefits in patients with heart failure irrespective of serum cholesterol levels or atherosclerotic heart disease.
Journal ArticleDOI

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.

TL;DR: Metformin attenuated oxidative stress–induced cardiomyocyte apoptosis and prevented the progression of heart failure in dogs, along with activation of AMPK, suggesting metformin may be a potential new therapy for heart failure.
Journal ArticleDOI

Natriuretic Peptides Enhance the Production of Adiponectin in Human Adipocytes and in Patients With Chronic Heart Failure

TL;DR: Natriuretic peptides enhance adiponectin production by human adipocytes in vitro and even in patients with CHF, which might have a beneficial effect on cardiomyocytes in patients receiving recombinant natriureic peptide therapy for heart failure.
Journal ArticleDOI

Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia

TL;DR: Acquiring direct flow based on the angiosome concept is important for limb salvage by EVT in patients with CLI, and it is significantly higher in the direct group than in the indirect group for up to 4 years after the procedure.